{
  "portfolio_id": "anya_sharma_portfolio",
  "owner_id": "user_42",
  "portfolio_name": "Dr. Anya Sharma's Investment Portfolio",
  "creation_date": "2023-08-15T10:00:00Z",
  "last_updated": "2025-03-08T16:20:00Z",
  "description": "Diversified portfolio aligned with Dr. Sharma's financial goals and ethical considerations.",
  "currency": "USD",
  "asset_allocation": {
    "stocks": 60,
    "bonds": 20,
    "alternative_investments": 10,
    "cash": 10
  },
  "risk_profile": "Moderate",
  "investment_horizon": "Long-term (10+ years)",
  "holdings": [
    {
      "asset_class": "stocks",
      "symbol": "AAPL",
      "quantity": 100,
      "purchase_date": "2023-09-15",
      "purchase_price": 150.00,
      "current_price": 175.00,
      "sector": "Technology",
      "industry": "Consumer Electronics",
      "esg_rating": "High",
      "notes": "Long-term growth potential, strong ESG profile."
    },
    {
      "asset_class": "stocks",
      "symbol": "MSFT",
      "quantity": 50,
      "purchase_date": "2023-10-20",
      "purchase_price": 250.00,
      "current_price": 280.00,
      "sector": "Technology",
      "industry": "Software",
      "esg_rating": "Medium",
      "notes": "Cloud computing leader, potential for AI expansion."
    },
    {
      "asset_class": "bonds",
      "symbol": "US10Y",
      "quantity": 100000,
      "purchase_date": "2024-01-15",
      "purchase_price": 100.00,
      "current_price": 102.00,
      "maturity_date": "2034-01-15",
      "coupon_rate": 3.0,
      "esg_rating": "Not Applicable",
      "notes": "Diversification, stable income stream."
    },
    {
      "asset_class": "alternative_investments",
      "symbol": "CRSP",
      "quantity": 50,
      "purchase_date": "2024-05-10",
      "purchase_price": 60.00,
      "current_price": 65.00,
      "description": "CRISPR Therapeutics AG",
      "sector": "Healthcare",
      "industry":"Biotechnology",
      "esg_rating": "High",
      "notes": "Gene editing technology, potential for transformative therapies."
    },
    {
      "asset_class": "alternative_investments",
      "symbol": "VEGN",
      "quantity": 100,
      "purchase_date": "2024-08-10",
      "purchase_price": 80.00,
      "current_price": 85.00,
      "description": "US Vegan Climate ETF",
      "sector":"Equity ETF",
      "industry":"Socially Responsible Investing",
      "esg_rating": "Very High",
      "notes":"ETF aligns with ethical and sustainable investment principles."
    },
    {
      "asset_class": "cash",
      "symbol": "USD",
      "quantity": 50000,
      "notes": "Liquidity for future investments and opportunities."
    }
  ],
  "performance_metrics": {
    "total_value": 286250,
    "annualized_return": 8.7,
    "risk_metrics": {
      "volatility": 0.12,
      "sharpe_ratio": 1.25
    }
  },
  "future_investments": [
    {
      "asset_class": "stocks",
      "symbol": "NVDA",
      "target_allocation": 5,
      "rationale": "Leading AI chip manufacturer, strong growth potential."
    },
    {
      "asset_class": "alternative_investments",
      "description": "Private Equity Fund focused on early stage AI safety companies",
      "target_allocation": 5,
      "rationale": "High-risk, high-reward potential in innovative AI safety solutions."
    }
  ],
  "portfolio_notes": "This portfolio is actively managed and adjusted based on market conditions, Dr. Sharma's financial goals, and ethical considerations. The focus is on long-term growth and impact investing. The inclusion of VEGN and CRSP reflect Dr. Sharma's strong ethical considerations."
}